Abstract
Alanine aminotransferase (ALT) and gamma-glutamyltransferase (GGT) are widely used markers of liver disease. Several population-based cohort studies have found associations of these liver enzymes with all-cause mortality. None of these studies controlled for genetic variation as well as fetal and early life exposure, whether environmental or genetic.
| Original language | English |
|---|---|
| Pages (from-to) | 1494-9 |
| Number of pages | 6 |
| Journal | Liver International |
| Volume | 29 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - Nov 2009 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Aged
- Aged, 80 and over
- Alanine Transaminase
- Cardiovascular Diseases
- Diabetes Mellitus
- Female
- Humans
- Longitudinal Studies
- Male
- Mortality
- Proportional Hazards Models
- gamma-Glutamyltransferase
Fingerprint
Dive into the research topics of 'Alanine aminotransferase, gamma-glutamyltransferase (GGT) and all-cause mortality: results from a population-based Danish twins study alanine aminotransferase, GGT and mortality in elderly twins'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver